Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Natural Health Trends (NHTC) Current Deferred Revenue (2016 - 2026)

Natural Health Trends (NHTC) has disclosed Current Deferred Revenue for 17 consecutive years, with $5.0 million as the latest value for Q1 2026.

  • For Q1 2026, Current Deferred Revenue fell 7.39% year-over-year to $5.0 million; the TTM value through Mar 2026 reached $5.0 million, down 7.39%, while the annual FY2025 figure was $4.1 million, 16.33% down from the prior year.
  • Current Deferred Revenue hit $5.0 million in Q1 2026 for Natural Health Trends, up from $4.1 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $7.6 million in Q2 2024 and bottomed at $3.8 million in Q4 2022.
  • Average Current Deferred Revenue over 5 years is $5.3 million, with a median of $5.1 million recorded in 2023.
  • Year-over-year, Current Deferred Revenue tumbled 41.54% in 2022 and then skyrocketed 83.95% in 2024.
  • Natural Health Trends' Current Deferred Revenue stood at $3.8 million in 2022, then surged by 62.26% to $6.2 million in 2023, then decreased by 20.53% to $4.9 million in 2024, then dropped by 16.33% to $4.1 million in 2025, then increased by 21.98% to $5.0 million in 2026.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $5.0 million, $4.1 million, and $4.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.